Commission Fines Lundbeck and other Pharma Companies for Delaying Market Entry of Generic Medicines: Statement by Vice-President Almunia
“Today the European Commission has found and sanctioned infringements of antitrust rules by several pharmaceutical companies. These companies entered into anticompetitive agreements to delay the entry of generic medicines on the market.
We have imposed fines… Read more